Get started
Author

Kevin Vella

Observed names: K. Vella, Vella, Kevin
Institution: Mater Dei Hospital
Observed institution: Mater Dei Hospital
ORCID: 0000-0002-0826-1921
Observed ORCID: 0000-0002-0826-1921
OpenAlex ID: A5061055563
Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin
2018 · Nicoletta Riva, Kevin Vella, et al. · Journal of Clinical Pathology · 30
Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.
2019 · Kirsty Rizzo, Kevin Vella, et al. · Blood transfusion · 21
PDF
Long COVID Syndrome: A Case-Control Study
2023 · Rachel-Anne Xuereb, Marica Borg, et al. · The American Journal of Medicine · 19
PDF
Navigating through the haemostatic paradox in kidney failure: A practical overview
2023 · Jessica Caruana, Nicoletta Riva, et al. · British Journal of Haematology · 15
PDF
A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment
2017 · N. Riva, K. Vella, et al. · International Journal of Laboratory Hematology · 14
Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: A systematic review and meta-analysis
2021 · Nicoletta Riva, Laura Maria Attard, et al. · Thrombosis Research · 13
PDF
The effect of DOAC‐Stop® on several oral and parenteral anticoagulants
2021 · Nicoletta Riva, Kevin Vella, et al. · International Journal of Laboratory Hematology · 11
A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban
2024 · Karl Mangion, Kevin Vella, et al. · Thrombosis Research · 7
PDF
Anticoagulation control with the point-of-care INR: A retrospective pre-/post-analysis
2020 · Nicoletta Riva, Stephanie Meli, et al. · Thrombosis Research · 1
An In Vitro Study Simulating Prophylactic Anticoagulation in Haemophilia A and B
2026 · Nicoletta Riva, Kevin Vella, et al. · eJHaem
PDF
A Comparative In Vitro Study of the Anticoagulant Effects of Branded versus Biosimilar Preparations of Enoxaparin
2026 · Alexander Gatt, Nicoletta Riva, et al. · Seminars in Thrombosis and Hemostasis
PB2155 An in vitro study of the effects of concizumab on different coagulation assays
2026 · Mattias Ellul, Kevin Vella, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB2765 A comparative in vitro study of the anticoagulant effects of branded vs biosimilar preparations of enoxaparin
2026 · Luca Sammut, Kevin Vella, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
PB3377 Characterising a cohort of Bleeding Disorders of Unknown Cause using modified Rotational Thromboelastometry; Thrombin Generation Assay and a Health related Quality of Life Questionnaire
2026 · Daniel Farrugia, Amy Marie Vella, et al. · Research and Practice in Thrombosis and Haemostasis
Diagnostic accuracy of D-dimer for splanchnic vein thrombosis : a systematic review and meta- analysis
2021 · Attard, Laura Maria, Vella, Kevin, et al. · OAR@UM (University of Malta)
PDF
Teaching an old dog new tricks?
2019 · Alex Gatt, Kevin Vella · British Journal of Haematology
Preface CPA 2017
2019 · Pedersen, Jan Bækgaard, Chalmers, Kevin, et al. · University of Twente Research Information
Works count: 17
Citation count: 131
H-index: 7
I10-index: 7
Year
Topic
Type